COVID-19 Vaccines & Treatments: Who Owns the Rights?

By P. Kandiah and Geetha Kandiah Moderna Inc., Sanofi, AstraZeneca plc, Roche, Gilead Sciences and Novartis are just some of the many pharmaceutical companies working to fast-track the development of a coronavirus vaccine. Many companies and research institutions from various countries are racing to develop the vaccine for COVID-19.

[BFM] 2016: Updates On Intellectual Property

In this Resource Centre segment, Geetha K. talks about whether you can protect an idea, how Malaysia performed in the 2015 Global IP Index, what Malaysian companies need to look into when it comes to their IP, and throws in a couple of noteworthy trademark cases for good measure! Your browser does not support native […]

[Malaysia SME] Southeast Asian countries’ performance in the International IP Index growing

By Geetha K. Southeast Asia has been attracting an increasing number of foreign direct investments. The emerging markets of Indonesia, Thailand, Malaysia, Philippines, Vietnam and Myanmar have been included in the expansion plans of most multinational corporations. In the 2015 ASEAN Business Outlook Survey, a report published by the US Chamber of Commerce in collaboration […]

[Business Today] Perception & Reality: IP rights enforcement in Malaysia

By P. Kandiah If one were to walk along the well-known streets of Kuala Lumpur often traversed by tourists, or patronize certain popular shopping complexes in the city, odds are one will find counterfeit merchandise such as watches, music CDs, digital video discs and T-shirts for sale. This brazen public display of knock-off products would […]

What does the TPPA have in store for patents?

By P. Kandiah At long last, the final draft of the Trans-Pacific Partnership Agreement (TPPA) has been officially published, with Chapter 18 of the draft dealing with Intellectual Property (IP) Rights. This article will examine the provisions relating to patents, though the chapter also deals with other IP Rights such as Trademark, Industrial Design, Copyright, […]